These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 1732385)

  • 1. Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis.
    Menon GK; Feingold KR; Mao-Qiang M; Schaude M; Elias PM
    J Invest Dermatol; 1992 Feb; 98(2):209-19. PubMed ID: 1732385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrier function regulates epidermal lipid and DNA synthesis.
    Proksch E; Holleran WM; Menon GK; Elias PM; Feingold KR
    Br J Dermatol; 1993 May; 128(5):473-82. PubMed ID: 8504036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acids are required for epidermal permeability barrier function.
    Mao-Qiang M; Elias PM; Feingold KR
    J Clin Invest; 1993 Aug; 92(2):791-8. PubMed ID: 8102380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamellar body secretory response to barrier disruption.
    Menon GK; Feingold KR; Elias PM
    J Invest Dermatol; 1992 Mar; 98(3):279-89. PubMed ID: 1545137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities.
    Kao JS; Fluhr JW; Man MQ; Fowler AJ; Hachem JP; Crumrine D; Ahn SK; Brown BE; Elias PM; Feingold KR
    J Invest Dermatol; 2003 Mar; 120(3):456-64. PubMed ID: 12603860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and biochemical basis for the UVB-induced alterations in epidermal barrier function.
    Holleran WM; Uchida Y; Halkier-Sorensen L; Haratake A; Hara M; Epstein JH; Elias PM
    Photodermatol Photoimmunol Photomed; 1997 Aug; 13(4):117-28. PubMed ID: 9453079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lovastatin-treated rodent: a new model of barrier disruption and epidermal hyperplasia.
    Feingold KR; Man MQ; Proksch E; Menon GK; Brown BE; Elias PM
    J Invest Dermatol; 1991 Feb; 96(2):201-9. PubMed ID: 1991980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation of the epidermal permeability barrier by lipids and hyperproliferation].
    Proksch E
    Hautarzt; 1992 Jun; 43(6):331-8. PubMed ID: 1628964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function.
    Holleran WM; Takagi Y; Menon GK; Legler G; Feingold KR; Elias PM
    J Clin Invest; 1993 Apr; 91(4):1656-64. PubMed ID: 8473508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory phospholipase A2 activity is required for permeability barrier homeostasis.
    Mao-Qiang M; Jain M; Feingold KR; Elias PM
    J Invest Dermatol; 1996 Jan; 106(1):57-63. PubMed ID: 8592082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model.
    Ghadially R; Brown BE; Sequeira-Martin SM; Feingold KR; Elias PM
    J Clin Invest; 1995 May; 95(5):2281-90. PubMed ID: 7738193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol synthesis is required for cutaneous barrier function in mice.
    Feingold KR; Man MQ; Menon GK; Cho SS; Brown BE; Elias PM
    J Clin Invest; 1990 Nov; 86(5):1738-45. PubMed ID: 2243142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The morphologic changes in lamellar bodies and intercorneocyte lipids after tape stripping and occlusion with a water vapor-impermeable membrane.
    Jiang S; Koo SW; Lee SH
    Arch Dermatol Res; 1998 Mar; 290(3):145-51. PubMed ID: 9558490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function.
    Kim M; Jung M; Hong SP; Jeon H; Kim MJ; Cho MY; Lee SH; Man MQ; Elias PM; Choi EH
    Exp Dermatol; 2010 Jun; 19(6):501-10. PubMed ID: 19703225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The permeability barrier in mammalian epidermis.
    Elias PM; Friend DS
    J Cell Biol; 1975 Apr; 65(1):180-91. PubMed ID: 1127009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of the permeability barrier abnormality in epidermolytic hyperkeratosis.
    Schmuth M; Yosipovitch G; Williams ML; Weber F; Hintner H; Ortiz-Urda S; Rappersberger K; Crumrine D; Feingold KR; Elias PM
    J Invest Dermatol; 2001 Oct; 117(4):837-47. PubMed ID: 11676820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of calcium in murine epidermis following disruption and repair of the permeability barrier.
    Menon GK; Elias PM; Lee SH; Feingold KR
    Cell Tissue Res; 1992 Dec; 270(3):503-12. PubMed ID: 1486603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase induce reductase accumulation and altered lamellar bodies in rat forestomach keratinocytes.
    Singer II; Kawka DW; Scott S; Bailey P; Kloss MW; Majka J; MacDonald JS
    Arterioscler Thromb; 1991; 11(5):1156-65. PubMed ID: 1911702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avian permeability barrier function reflects mode of sequestration and organization of stratum corneum lipids: reevaluation utilizing ruthenium tetroxide staining and lipase cytochemistry.
    Menon GK; Hou SY; Elias PM
    Tissue Cell; 1991; 23(4):445-56. PubMed ID: 1718053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of cholesterol synthesis in liver versus extrahepatic tissues by HMG-CoA reductase inhibitors.
    Parker RA; Clark RW; Sit SY; Lanier TL; Grosso RA; Wright JJ
    J Lipid Res; 1990 Jul; 31(7):1271-82. PubMed ID: 2401858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.